MedPath

To study different mutations in filaggrin gene and their correlation with clinical and laboratory parameters in adults having atopic dermatitis

Not Applicable
Conditions
Health Condition 1: L208- Other atopic dermatitis
Registration Number
CTRI/2021/03/032308
Lead Sponsor
Anuradha Bishnoi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Age at presentation more than 18 years

Active atopic dermatitis, diagnosis of which shall be made on 2 grounds: 1. Fulfillment of Hanifin and Rajkaâ??s original criteria, and 2. Expert opinion where 3 independent eczema experts shall decide whether or not a patient has atopic dermatitis and the cases where all the experts decide unanimously on the diagnosis shall be recruited in the present study.

Willing to undergo filaggrin mutation status assessment, serum IgE levels (total and specific) and patch testing with atopic patch tests and standard patch testing with Indian standard series.

Exclusion Criteria

Pregnancy and lactation

Any immunocompromised state

Isolated hand eczema in absence of any other lesions of atopic dermatitis on body.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess the frequency of selected filaggrin mutations in adults having atopic dermatitis.Timepoint: Baseline only
Secondary Outcome Measures
NameTimeMethod
To see whether the presence of any of these mutations in adults having atopic dermatitis has a correlation with <br/ ><br>1.Age of onset of eczema (pediatric-onset vs adult-onset AD) and its duration <br/ ><br>2.Severity of eczema at presentation <br/ ><br>3.Levels of total and specific serum IgE levels at presentation <br/ ><br>4.Results of atopy patch tests and standard patch tests carried out with Indian standard series. <br/ ><br>Timepoint: Baseline only
© Copyright 2025. All Rights Reserved by MedPath